Development of novel octanoyl chitosan nanoparticles for improved rifampicin pulmonary delivery: optimization by factorial design

KC Petkar, S Chavhan, N Kunda, I Saleem… - AAPS …, 2018 - Springer
A novel hydrophobic chitosan derivative, octanoyl chitosan (OC) with improved organic
solubility was synthesized, characterized, and employed for the preparation of rifampicin …

Development of chitosan-based nanoparticles for pulmonary delivery of itraconazole as dry powder formulation

S Jafarinejad, K Gilani, E Moazeni, M Ghazi-Khansari… - Powder technology, 2012 - Elsevier
The aim of current study was to illustrate a strategy to encapsulate itraconazole into chitosan-
based nanoparticles using a modified ionic gelation method and to fabricate them as …

Development and evaluation of chitosan microparticles based dry powder inhalation formulations of rifampicin and rifabutin

RV Pai, RR Jain, AS Bannalikar… - Journal of aerosol …, 2016 - liebertpub.com
Background: The lung is the primary entry site and target for Mycobacterium tuberculosis;
more than 80% of the cases reported worldwide are of pulmonary tuberculosis. Hence …

Rifampicin loaded chitosan nanoparticle dry powder presents an improved therapeutic approach for alveolar tuberculosis

T Rawal, R Parmar, RK Tyagi, S Butani - Colloids and Surfaces B …, 2017 - Elsevier
Current treatment therapeutic approach for tuberculosis is the administration of first line
drugs in the form of tablets and capsules for 4–6 months. However, this approach leads to …

Nicotine hydrogen tartrate loaded chitosan nanoparticles: Formulation, characterization and in vitro delivery from dry powder inhaler formulation

H Wang, G George, S Bartlett, C Gao, N Islam - European Journal of …, 2017 - Elsevier
This study reports the development of nanoparticles in the form of inhalable micro-
aggregates of biodegradable chitosan (CS) loaded with nicotine hydrogen tartrate (NHT) for …

Nanocrystals embedded in chitosan-based respirable swellable microparticles as dry powder for sustained pulmonary drug delivery

R Ni, J Zhao, Q Liu, Z Liang, U Muenster… - European Journal of …, 2017 - Elsevier
In this study, nanocrystals embedded in microparticles were designed to achieve sustained
pulmonary drug delivery of hydrophobic drugs. Chitosan based microparticles were …

Inhalable chitosan nanoparticles as antitubercular drug carriers for an effective treatment of tuberculosis

T Garg, G Rath, AK Goyal - Artificial cells, nanomedicine, and …, 2016 - Taylor & Francis
The aim of this study was to prepare and characterize spray dried inhalable chitosan
nanoparticles (CNPs) for sustained delivery of anti-tubercular drugs, isoniazid (INH) and …

Preparation, in vitro characterization, and in vivo pharmacokinetic evaluation of respirable porous microparticles containing rifampicin

A Kundawala, V Patel, H Patel, D Choudhary - Scientia pharmaceutica, 2014 - mdpi.com
This study aimed to prepare and evaluate rifampicin microparticles for the lung delivery of
rifampicin as respirable powder. The microparticles were prepared using chitosan by the …

Preparation and characterization of spray dried inhalable powders containing chitosan nanoparticles for pulmonary delivery of isoniazid

PS Pourshahab, K Gilani, E Moazeni… - Journal of …, 2011 - Taylor & Francis
The aim of this study was to prepare spray dried inhalable powders containing isoniazid-
loaded chitosan/tripolyphosphate (TPP) nanoparticles for sustained delivery of the drug to …

Porous particles and novel carrier particles with enhanced penetration for efficient pulmonary delivery of antitubercular drugs

JY Tse, A Koike, K Kadota, H Uchiyama… - European Journal of …, 2021 - Elsevier
This study aimed to design dry powder inhaler formulations using a hydrophilic polymeric
polysaccharide, phytoglycogen (PyG), as a multi-functional additive that increases the …